▶ 調査レポート

β遮断薬のグローバル市場インサイト・予測(~2025年)

• 英文タイトル:Global β-blockers Market Insights, Forecast to 2025

Global β-blockers Market Insights, Forecast to 2025「β遮断薬のグローバル市場インサイト・予測(~2025年)」(市場規模、市場予測)調査レポートです。• レポートコード:MRC0FB03244
• 出版社/出版日:QYResearch / 2019年12月
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥429,000 (USD3,900)▷ お問い合わせ
  Multi User¥643,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥858,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートでは、世界のβ遮断薬市場について調査・分析し、以下の構成でお届け致します。β遮断薬の種類別には、非選択的エージェント、選択的エージェントに、用途別には、異常な心臓リズム、高血圧に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別β遮断薬売上データ
・地域別β遮断薬市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別β遮断薬市場規模:非選択的エージェント、選択的エージェント
・用途別β遮断薬市場規模:異常な心臓リズム、高血圧
・主要メーカーの企業情報:Pfizer、Novartis、Merck、Astra Zeneca、Jhonson and Johnson、Eli Lilly、Sanofi、Bristol-Myers Squibb、Bayer、GSK、Teva Pharmaceutical
・β遮断薬の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

β-blockers are a class of medications that are predominantly used to manage abnormal heart rhythms, and to protect the heart from a second heart attack (myocardial infarction) after a first heart attack (secondary prevention). They are also widely used to treat high blood pressure (hypertension), although they are no longer the first choice for initial treatment of most patients.The global β-blockers market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the β-blockers market based on company, product type, end user and key regions.

This report studies the global market size of β-blockers in key regions like North America, Europe, China and Japan, focuses on the consumption of β-blockers in these regions.
This research report categorizes the global β-blockers market by top players/brands, region, type and end user. This report also studies the global β-blockers market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical

β-blockers market size by Type
Nonselective Agents
Selective Agents

β-blockers market size by Applications
Abnormal Heart Rhythms
Hypertension

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global β-blockers market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of β-blockers market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global β-blockers companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of β-blockers submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of β-blockers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of β-blockers market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Study Coverage
1.1 β-blockers Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global β-blockers Market Size Growth Rate by Type
1.4.2 Nonselective Agents
1.4.3 Selective Agents
1.5 Market by Application
1.5.1 Global β-blockers Market Size Growth Rate by Application
1.5.2 Abnormal Heart Rhythms
1.5.3 Hypertension
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global β-blockers Market Size
2.1.1 Global β-blockers Revenue 2014-2025
2.1.2 Global β-blockers Sales 2014-2025
2.2 β-blockers Growth Rate by Regions
2.2.1 Global β-blockers Sales by Regions
2.2.2 Global β-blockers Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 β-blockers Sales by Manufacturers
3.1.1 β-blockers Sales by Manufacturers
3.1.2 β-blockers Sales Market Share by Manufacturers
3.2 β-blockers Revenue by Manufacturers
3.2.1 β-blockers Revenue by Manufacturers (2014-2019)
3.2.2 β-blockers Revenue Share by Manufacturers (2014-2019)
3.3 β-blockers Price by Manufacturers
3.4 β-blockers Manufacturing Base Distribution, Product Types
3.4.1 β-blockers Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers β-blockers Product Type
3.4.3 Date of International Manufacturers Enter into β-blockers Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global β-blockers Sales by Type
4.2 Global β-blockers Revenue by Type
4.3 β-blockers Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global β-blockers Breakdown Data by Application

6 North America
6.1 North America β-blockers by Country
6.1.1 North America β-blockers Sales by Country
6.1.2 North America β-blockers Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America β-blockers by Type
6.3 North America β-blockers by Application

7 Europe
7.1 Europe β-blockers by Country
7.1.1 Europe β-blockers Sales by Country
7.1.2 Europe β-blockers Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe β-blockers by Type
7.3 Europe β-blockers by Application

8 Asia Pacific
8.1 Asia Pacific β-blockers by Region
8.1.1 Asia Pacific β-blockers Sales by Region
8.1.2 Asia Pacific β-blockers Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific β-blockers by Type
8.3 Asia Pacific β-blockers by Application

9 Central & South America
9.1 Central & South America β-blockers by Country
9.1.1 Central & South America β-blockers Sales by Country
9.1.2 Central & South America β-blockers Revenue by Country
9.1.3 Brazil
9.2 Central & South America β-blockers by Type
9.3 Central & South America β-blockers by Application

10 Middle East and Africa
10.1 Middle East and Africa β-blockers by Country
10.1.1 Middle East and Africa β-blockers Sales by Country
10.1.2 Middle East and Africa β-blockers Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa β-blockers by Type
10.3 Middle East and Africa β-blockers by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer β-blockers Products Offered
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Business Overview
11.2.3 Novartis β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis β-blockers Products Offered
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.3 Merck β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck β-blockers Products Offered
11.3.5 Merck Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Company Business Overview
11.4.3 Astra Zeneca β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Astra Zeneca β-blockers Products Offered
11.4.5 Astra Zeneca Recent Development
11.5 Jhonson and Johnson
11.5.1 Jhonson and Johnson Company Details
11.5.2 Company Business Overview
11.5.3 Jhonson and Johnson β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Jhonson and Johnson β-blockers Products Offered
11.5.5 Jhonson and Johnson Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Company Business Overview
11.6.3 Eli Lilly β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Eli Lilly β-blockers Products Offered
11.6.5 Eli Lilly Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Business Overview
11.7.3 Sanofi β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Sanofi β-blockers Products Offered
11.7.5 Sanofi Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Company Business Overview
11.8.3 Bristol-Myers Squibb β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Bristol-Myers Squibb β-blockers Products Offered
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Company Business Overview
11.9.3 Bayer β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bayer β-blockers Products Offered
11.9.5 Bayer Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 Company Business Overview
11.10.3 GSK β-blockers Sales, Revenue and Gross Margin (2014-2019)
11.10.4 GSK β-blockers Products Offered
11.10.5 GSK Recent Development
11.11 Teva Pharmaceutical

12 Future Forecast
12.1 β-blockers Market Forecast by Regions
12.1.1 Global β-blockers Sales Forecast by Regions 2019-2025
12.1.2 Global β-blockers Revenue Forecast by Regions 2019-2025
12.2 β-blockers Market Forecast by Type
12.2.1 Global β-blockers Sales Forecast by Type 2019-2025
12.2.2 Global β-blockers Revenue Forecast by Type 2019-2025
12.3 β-blockers Market Forecast by Application
12.4 North America β-blockers Forecast
12.5 Europe β-blockers Forecast
12.6 Asia Pacific β-blockers Forecast
12.7 Central & South America β-blockers Forecast
12.8 Middle East and Africa β-blockers Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 β-blockers Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure β-blockers Product Picture
Table β-blockers Market Segments
Table Key Manufacturers β-blockers Covered
Table Global β-blockers Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global β-blockers Sales Market Share by Type in 2018 & 2025
Figure Nonselective Agents Product Picture
Table Major Manufacturers of Nonselective Agents
Figure Selective Agents Product Picture
Table Major Manufacturers of Selective Agents
Table Global β-blockers Market Size Growth Rate by Application 2019-2025 (K Units)
Figure Global β-blockers 4900 Sales Market Share by Application in 2018
Figure Abnormal Heart Rhythms
Figure Hypertension
Figure β-blockers Report Years Considered
Figure Global β-blockers Market Size 2014-2025 (Million US$)
Figure Global β-blockers Sales 2014-2025 (K Units)
Table Global β-blockers Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global β-blockers Sales by Regions 2014-2019 (K Units)
Table Global β-blockers Sales Market Share by Regions 2014-2019
Figure Global β-blockers Sales Market Share by Regions 2014-2019
Figure 2018 Global β-blockers Sales Market Share by Regions
Table Global β-blockers Revenue by Regions 2014-2019 (Million US$)
Table Global β-blockers Revenue Market Share by Regions 2014-2019
Figure Global β-blockers Revenue Market Share by Regions 2014-2019
Figure 2018 Global β-blockers Revenue Market Share by Regions
Table Global β-blockers Sales by Manufacturers (2014-2019) (K Units)
Table Global β-blockers Sales Share by Manufacturers (2014-2019)
Figure Global β-blockers Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table β-blockers Revenue by Manufacturers (2014-2019) (Million USD)
Table β-blockers Revenue Share by Manufacturers (2014-2019)
Figure β-blockers Value Share by Manufacturers in 2018
Table Key Manufacturers β-blockers Price (2014-2019) (USD/Unit)
Table β-blockers Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers β-blockers Product Type
Table Date of International Manufacturers Enter into β-blockers Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global β-blockers Sales by Type (2014-2019) (K Units)
Table Global β-blockers Sales Share by Type (2014-2019)
Figure Global β-blockers Sales Market Share by Type (2014-2019)
Figure Global β-blockers Sales Market Share by Type in 2018
Table Global β-blockers Revenue by Type (2014-2019) (Million US$)
Table Global β-blockers Revenue Share by Type (2014-2019)
Figure Global β-blockers Revenue Market Share by Type (2014-2019)
Figure Global β-blockers Revenue Market Share by Type in 2018
Table β-blockers Price by Type 2014-2019 (USD/Unit)
Table Global β-blockers Sales by Application (2014-2019) (K Units)
Table Global β-blockers Sales Share by Application (2014-2019)
Figure Global Sales β-blockers Market Share by Application (2014-2019)
Figure Global Sales β-blockers Market Share by Application in 2018
Figure North America β-blockers Sales Growth Rate 2014-2019 (K Units)
Figure North America β-blockers Revenue Growth Rate 2014-2019 (Million US$)
Table North America β-blockers Sales by Country (2014-2019) (K Units)
Table North America β-blockers Sales Market Share by Country (2014-2019)
Figure 2018 North America β-blockers Sales Market Share by Country
Table North America β-blockers Revenue by Country (2014-2019) (Million US$)
Table North America β-blockers Revenue Market Share by Country (2014-2019)
Figure 2018 North America β-blockers Revenue Market Share by Country
Figure United States β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure United States β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Canada β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Canada β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Mexico β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Table North America β-blockers Sales by Type (2014-2019) (K Units)
Table North America β-blockers Sales Market Share by Type (2014-2019)
Figure 2018 North America β-blockers Market Share by Type
Table North America β-blockers Sales by Application (2014-2019) (K Units)
Table North America β-blockers Sales Market Share by Application (2014-2019)
Figure 2018 North America β-blockers Market Share by Application
Figure Europe β-blockers Sales Growth Rate 2014-2019 (K Units)
Figure Europe β-blockers Revenue Growth Rate 2014-2019 (Million US$)
Table Europe β-blockers Sales by Country (2014-2019) (K Units)
Table Europe β-blockers Sales Market Share by Country (2014-2019)
Figure 2018 Europe β-blockers Sales Market Share by Country
Table Europe β-blockers Revenue by Country (2014-2019) (Million US$)
Table Europe β-blockers Revenue Market Share by Country (2014-2019)
Figure 2018 Europe β-blockers Revenue Market Share by Country
Figure Germany β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Germany β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure France β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure France β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure UK β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure UK β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Italy β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Russia β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Table Europe β-blockers Sales by Type (2014-2019) (K Units)
Table Europe β-blockers Sales Market Share by Type (2014-2019)
Figure 2018 Europe β-blockers Market Share by Type
Table Europe β-blockers Sales by Application (2014-2019) (K Units)
Table Europe β-blockers Sales Market Share by Application (2014-2019)
Figure 2018 Europe β-blockers Market Share by Application
Figure Asia Pacific β-blockers Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific β-blockers Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific β-blockers Sales by Region (2014-2019) (K Units)
Table Asia Pacific β-blockers Sales Market Share by Region (2014-2019)
Figure 2018 Asia Pacific β-blockers Sales Market Share by Region
Table Asia Pacific β-blockers Revenue by Region (2014-2019) (Million US$)
Table Asia Pacific β-blockers Revenue Market Share by Region (2014-2019)
Figure 2018 Asia Pacific β-blockers Revenue Market Share by Country
Figure China β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure China β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Japan β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure South Korea β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure South Korea β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure India β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure India β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Australia β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Thailand β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Philippines β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific β-blockers Sales by Type (2014-2019) (K Units)
Table Asia Pacific β-blockers Sales Market Share by Type (2014-2019)
Figure 2018 Asia Pacific β-blockers Market Share by Type
Table Asia Pacific β-blockers Sales by Application (2014-2019) (K Units)
Table Asia Pacific β-blockers Sales Market Share by Application (2014-2019)
Figure 2018 Asia Pacific β-blockers Market Share by Application
Figure Central & South America β-blockers Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America β-blockers Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America β-blockers Sales by Country (2014-2019) (K Units)
Table Central & South America β-blockers Sales Market Share by Country (2014-2019)
Figure 2018 Central & South America β-blockers Sales Market Share by Country
Table Central & South America β-blockers Revenue by Country (2014-2019) (Million US$)
Table Central & South America β-blockers Revenue Market Share by Country (2014-2019)
Figure 2018 Central & South America β-blockers Revenue Market Share by Country
Figure Brazil β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Brazil β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America β-blockers Sales by Type (2014-2019) (K Units)
Table Central & South America β-blockers Sales Market Share by Type (2014-2019)
Figure 2018 Central & South America β-blockers Market Share by Type
Table Central & South America β-blockers Sales by Application (2014-2019) (K Units)
Table Central & South America β-blockers Sales Market Share by Application (2014-2019)
Figure 2018 Central & South America β-blockers Market Share by Application
Figure Middle East and Africa β-blockers Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa β-blockers Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa β-blockers Sales by Country (2014-2019) (K Units)
Table Middle East and Africa β-blockers Sales Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa β-blockers Sales Market Share by Country
Table Middle East and Africa β-blockers Revenue by Country (2014-2019) (Million US$)
Table Middle East and Africa β-blockers Revenue Market Share by Country (2014-2019)
Figure 2018 Middle East and Africa β-blockers Revenue Market Share by Country
Figure Turkey β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Turkey β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure GCC Countries β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure Egypt β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa β-blockers Sales Growth Rate (2014-2019) (K Units)
Figure South Africa β-blockers Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa β-blockers Sales by Type (2014-2019) (K Units)
Table Middle East and Africa β-blockers Sales Market Share by Type (2014-2019)
Figure 2018 Middle East and Africa β-blockers Market Share by Type
Table Middle East and Africa β-blockers Sales by Application (2014-2019) (K Units)
Table Middle East and Africa β-blockers Sales Market Share by Application (2014-2019)
Figure 2018 Middle East and Africa β-blockers Market Share by Application
Table Pfizer Company Details
Table Pfizer β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Novartis Company Details
Table Novartis β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development

Table Merck Company Details
Table Merck β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development

Table Astra Zeneca Company Details
Table Astra Zeneca β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Astra Zeneca Recent Development

Table Jhonson and Johnson Company Details
Table Jhonson and Johnson β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Jhonson and Johnson Recent Development

Table Eli Lilly Company Details
Table Eli Lilly β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development

Table Sanofi Company Details
Table Sanofi β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development

Table Bayer Company Details
Table Bayer β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Recent Development

Table GSK Company Details
Table GSK β-blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recent Development

Table Teva Pharmaceutical Company Details
Table Global β-blockers Sales Forecast by Regions 2019-2025 (K Units)
Table Global β-blockers Sales Market Share Forecast by Regions 2019-2025
Table Global β-blockers Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global β-blockers Revenue Market Share Forecast by Regions 2019-2025
Table Global β-blockers Sales Forecast by Type 2019-2025 (K Units)
Table Global β-blockers Sales Market Share Forecast by Type 2019-2025
Table Global β-blockers Revenue Forecast by Type 2019-2025 (Million US$)
Table Global β-blockers Revenue Market Share Forecast by Type 2019-2025
Table Global β-blockers Sales Forecast by Application 2019-2025 (K Units)
Table Global β-blockers Sales Market Share Forecast by Application 2019-2025
Figure North America β-blockers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America β-blockers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe β-blockers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe β-blockers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific β-blockers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific β-blockers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America β-blockers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America β-blockers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa β-blockers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa β-blockers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Key Opportunities and Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Table Market Risks
Figure Porter's Five Forces Analysis
Table β-blockers Value Chain
Table β-blockers Customers List
Figure Channels of Distribution
Table β-blockers Distributors List
Figure Distributors Profiles
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources